Cytokinetics, Inc. (NASDAQ:CYTK) shares dropped by 2.59%, Lifevantage Corporation (NASDAQ:LFVN)

Posted by Ryan Mandell May 29, 2013 0 Comment 1113 views


Hartford, CT 05/29/2013 (GDPInsider) – Cytokinetics, Inc. (NASDAQ:CYTK) shares closed at $1.13 dropped by 2.59% (-$0.03) compared to previous day’s close of about $1.16. It touched a high of $1.17 and low of $1.11 during the day. It is about 23.29% below its 52 week high of $1.46 and about 96.49% above its 52-week low of $0.57. Around 0.813 million Shares have exchanged hands during last trading session which is lower as compared to average shares changed during a period of 30 days which is 1.47 million. The market capitalization of the company is $165.36 million. The earnings per share of the company are -$0.37 which shows that the company is incurring losses. The average true range of the stock is 0.08. The high current ratio of the company 10.94 shows good capital working capital management. The beta of the company is 1.81.

Cytokinetics held its annual meeting of stock holders in California and at the meeting about 1.46 billion shares of the common stock of the company was voted out of which 73.03% shares were represented in the meeting.

Is CYTK a solid investment at these levels? Get valuable updates and exclusive insights here.

Lifevantage Corporation (NASDAQ:LFVN) shares closed at $2.35 dropped by 0.42% (-$0.01) compared to previous day’s close of about $2.36. It touched a high of $2.38 and low of $2.30 during the day. It is about 39.61% below its 52 week high of $3.85 and about 45.31% above its 52-week low of $1.60. Around 0.261 million Shares have exchanged hands during last trading session which is lower as compared to average shares changed during a period of 30 days which is 0.441 million. The market capitalization of the company is $264.45 million. The earnings per share of the company are $0.03 which shows that the company is enjoying profits. The average true range of the stock is 0.09. The high current ratio of the company 2.37 shows good capital working capital management. The beta of the company is 1.48.

How Should Investors Trade LFVN Now? Get key and important information right here.

Disclosure:

WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.


About Ryan Mandell

Ryan Mandell is our senior staff writer covering the White House for Political Report, Ryan also coordinates with the main newsroom news items and contributing write-ups on cultural, social and political activities. Ryan holds an undergraduate degree in journalism, a Doctorate in international relations and a Master Degree in mass communications with an emphasis in print journalism. Ryan also covered the International Society of Social Defense congress in Spain in 2007 and taken part in the Global Forum on economic policies

View all post by Ryan Mandell Visit author's website

Write Your Comment